Chemours Appoints Guillaume Pepy to Board of Directors

WILMINGTON, Del.--(BUSINESS WIRE)-- The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, announces the appointment of Guillaume Pepy to its board of directors.

“Guillaume’s background and experience are impressive, especially his deep understanding of the European market and direct work in using technology as a catalyst for strengthening customer relationships and keeping their needs at the center of critical decisions,” said Dawn Farrell, chair of the board of directors at Chemours. “We look forward to his contributions to our board as Chemours works to realize the full potential of its business.”

Guillaume Pepy, 63, is the former chairman and chief executive officer of SNCF Group, a state-owned French railway and logistics solutions company where he spent nearly 26 years of his career. In 2019, after more than ten years as chairman and CEO, Mr. Pepy stepped down from SNCF to pursue new endeavors, focusing on various board and advisory roles. Before joining SNCF, Mr. Pepy held high-ranking civil service positions in several French ministries.

Mr. Pepy is a graduate of Sciences Po and École Nationale d’Administration in France. He served as Chairman of Eurostar and as a director of the mobility and logistics services operator Keolis Group. He currently chairs the board of Lydec S.A., the Moroccan subsidiary of Suez, a global environmental services and utility provider. Mr. Pepy serves as a Senior Advisor to the Canadian Pension Plan Investment Board (CPPIB), Salesforce in EMEA, and The Boston Consulting Group. Mr. Pepy also chairs Initiative France – a nonprofit that helps aspiring entrepreneurs create businesses.

"Guillaume brings a wealth of public and government sector experience in addition to expert perspective and insights into the regulatory and environmental landscapes in Europe,” said Mark Newman, president and chief executive officer of Chemours. “Combined with his history of leading successful business transformations, I am confident that Guillaume will make many meaningful contributions to Chemours’ sustainable growth in this next chapter of our company.”

Mr. Pepy’s appointment to the board of directors went into effect on February 8, 2022.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration, and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas. Our flagship products include prominent brands such as Ti-Pure™, Opteon™, Freon™, Teflon™, Viton™, Nafion™, and Krytox™. The company has approximately 6,400 employees and 29 manufacturing sites serving approximately 3,200 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words “believe," “expect," “will," “anticipate," “plan," “estimate," “target," “project” and similar expressions, among others, generally identify “forward-looking statements,” which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the current COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is still being determined and to date has included significant volatility in financial and commodity markets and a severe disruption in economic activity. The public and private sector response has led to travel restrictions, temporary business closures, quarantines, stock market volatility, and interruptions in consumer and commercial activity globally. Matters outside our control have affected our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2021. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

Source: The Chemours Company